Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC |
CARUSO RICHARD E10% owner
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,250 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · derivative · entry 7 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,878 Underlying: Common Stock · 9,250 shares Expires 2019-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the stock options vest every quarter from the grant date of 5/17/2011 F2 · balance_after: This option was previously reported as covering 4,431 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 4,625 shares of common stock at an exercise price of $43.93 per share. F3 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC |
CARUSO RICHARD E10% owner
|
SaleCommon Stock | 20,878 | $56.06 | $1,170,406.07 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 4 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,134 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC |
CARUSO RICHARD E10% owner
|
Exercise / conversionCommon Stock | 20,878 | $21.97 | $458,585.27 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 3 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC |
CARUSO RICHARD E10% owner
|
SaleCommon Stock | 9,250 | $56.06 | $518,548.53 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 2 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,134 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:17 UTC |
CARUSO RICHARD E10% owner
|
Exercise / conversionCommon Stock | 9,250 | $21.97 | $203,176.25 |
DisclosureSEC source: 0001209191-19-019753 · doc4.xml · nonDerivative · entry 1 CARUSO RICHARD E · CIK 0001187576 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 20,678 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · derivative · entry 8 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,678 Underlying: Common Stock · 20,678 shares Expires 2027-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, and third anniversaries of the grant date of 3/13/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 718 | $55.91 | $40,143.38 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 5 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,231 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 856 | $55.91 | $47,858.96 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 4 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,949 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 4,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 3 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,805 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 1,191 | $55.91 | $66,588.81 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 2 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,184 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 2,232 | $55.91 | $124,791.12 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,375 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,795 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · derivative · entry 8 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,795 Underlying: Common Stock · 3,795 shares Expires 2027-03-13 F1 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/13/2019. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
GrantCommon Stock | 848 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 5 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,050 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 94 | $55.91 | $5,255.54 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 4 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,202 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 117 | $55.91 | $6,541.47 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 3 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,296 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 208 | $55.91 | $11,629.28 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 2 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,413 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 437 | $55.91 | $24,432.67 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 1 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,621 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
GrantRestricted Stock Units/Contract Stock · Derivative | 20,390 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 13 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,118 Underlying: Common Stock · 20,390 shares Expires not disclosed F4 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2019 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F4 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2019 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. F4 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/2019 which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. This award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Exercise / conversionRestricted Stock Units/Contract Stock · Derivative | 258 | $55.91 Strike: $0.00 | $14,424.78 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 12 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,728 Underlying: Common Stock · 258 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/18 of which the first installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. F3 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/18 of which the first installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. F3 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/18 of which the first installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Exercise / conversionRestricted Stock Units/Contract Stock · Derivative | 290 | $55.91 Strike: $0.00 | $16,213.90 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 11 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484,986 Underlying: Common Stock · 290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/17 of which the second installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. F2 · derivative.exercise_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/17 of which the second installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. F2 · derivative.expiration_date: The award was a contract stock unit award which will vest in three annual equal installments on the first, second and third anniversaries of the grant date of 3/13/17 of which the second installment vested on 3/13/19 and which shall be delivered to Mr. Arduini within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 91,249 | $0.00 Strike: $55.91 | $0.00 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · derivative · entry 10 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,249 Underlying: Common Stock · 91,249 shares Expires 2027-03-13 F1 · derivative.exercise_date: The grant will vest as to one-third of the shares on the first anniversary of the grant date of 3/13/2019 and thereafter in monthly installments through the following twenty-four months. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Tax withholdingCommon Stock | 11,687 | $55.91 | $653,420.17 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 6 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,309 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Tax withholdingCommon Stock | 6,215 | $55.91 | $347,480.65 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 5 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,996 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Tax withholdingCommon Stock | 258 | $55.91 | $14,424.78 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 4 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,211 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Exercise / conversionCommon Stock | 258 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 3 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,469 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Tax withholdingCommon Stock | 290 | $55.91 | $16,213.90 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,211 Read SEC document |
| March 13, 2019 Filed Mar 15, 2019 21:15 UTC |
Arduini Peter JDirector · President & CEO
|
Exercise / conversionCommon Stock | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-019749 · doc4.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:33 UTC |
Schwartz EricCorp VP, Gen Counsel & Sec
|
GrantCommon Stock | 17,851 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016527 · doc4.xml · nonDerivative · entry 1 Schwartz Eric · CIK 0001329100 · Corp VP, Gen Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,586 Read SEC document |
| February 17, 2019 Filed Feb 20, 2019 23:15 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 34 | $51.06 | $1,736.04 |
DisclosureSEC source: 0001209191-19-011762 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,444 Read SEC document |
| February 17, 2019 Filed Feb 20, 2019 23:15 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon stock | 7 | $51.06 | $357.42 |
DisclosureSEC source: 0001209191-19-011762 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,478 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:16 UTC |
Evoli LisaChief Human Resources Officer
|
GrantCommon Stock | 874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011198 · doc4.xml · nonDerivative · entry 3 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,283 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:16 UTC |
Evoli LisaChief Human Resources Officer
|
GrantCommn Stock | 1,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011198 · doc4.xml · nonDerivative · entry 2 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,409 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:16 UTC |
Evoli LisaChief Human Resources Officer
|
GrantCommon Stock | 1,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011198 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,020 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:11 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
GrantCommon Stock | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011192 · doc4.xml · nonDerivative · entry 3 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,058 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:11 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
GrantCommon Stock | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011192 · doc4.xml · nonDerivative · entry 2 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,454 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:11 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
GrantCommon Stock | 1,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011192 · doc4.xml · nonDerivative · entry 1 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,191 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:09 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
GrantCommon Stock | 1,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 3 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,108 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:09 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
GrantCommon Stock | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 2 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,638 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:09 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
GrantCommon Stock | 1,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011190 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,513 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:05 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
GrantCommon Stock | 1,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011174 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,761 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:05 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
GrantCommon Stock | 3,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011174 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,120 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:05 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
GrantCommon Stock | 3,759 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011174 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,579 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:07 UTC |
OGRADY JUDITHCorpVP,Global Reg.Affairs
|
GrantCommon Stock | 320 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 3 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,113 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:07 UTC |
OGRADY JUDITHCorpVP,Global Reg.Affairs
|
GrantCommon Stock | 708 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 2 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,793 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 22:07 UTC |
OGRADY JUDITHCorpVP,Global Reg.Affairs
|
GrantCommon Stock | 801 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011183 · doc4.xml · nonDerivative · entry 1 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,085 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:58 UTC |
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
|
GrantCommon Stock | 485 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 3 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,308 F3 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:58 UTC |
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
|
GrantCommon Stock | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 2 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,823 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:58 UTC |
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
|
GrantCommon Stock | 972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011140 · doc4.xml · nonDerivative · entry 1 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,973 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:56 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
GrantCommon Stock | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011136 · doc4.xml · nonDerivative · entry 2 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,467 F2 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 21:56 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
GrantCommon Stock | 654 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-011136 · doc4.xml · nonDerivative · entry 1 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,137 F1 · shares: On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.